Cargando…
Microglial inflammation and phagocytosis in Alzheimer's disease: Potential therapeutic targets
One of the largest unmet medical needs is a disease‐modifying treatment for Alzheimer's disease (AD). Recently, the role of microglia in disease, particularly AD, has gained great interest, following the identification of several disease risk‐associated genes that are highly expressed in microg...
Autores principales: | Nizami, Sohaib, Hall‐Roberts, Hazel, Warrier, Sharat, Cowley, Sally A., Di Daniel, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6715590/ https://www.ncbi.nlm.nih.gov/pubmed/30740661 http://dx.doi.org/10.1111/bph.14618 |
Ejemplares similares
-
Metabolic regulation of microglial phagocytosis: Implications for Alzheimer's disease therapeutics
por: Lepiarz-Raba, Izabela, et al.
Publicado: (2023) -
Cellular response to β‐amyloid neurotoxicity in Alzheimer's disease and implications in new therapeutics
por: Zhang, Haolin, et al.
Publicado: (2023) -
Microglial Phagocytosis—Rational but Challenging Therapeutic Target in Multiple Sclerosis
por: Pinto, Maria V., et al.
Publicado: (2020) -
Interactions between malaria and human immunodeficiency virus anno 2014
por: Van geertruyden, J-P
Publicado: (2014) -
Endophthalmitis
por: Durand, M L
Publicado: (2013)